Skip to main content

ATM and Cellular Response to DNA Damage

  • Chapter
Genome Instability in Cancer Development

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 570))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abraham, R.T. 2001. Cell cycle checkpoint signalling through the ATM and ATR kinases. Genes Dev. 15: 2177–2196.

    Article  CAS  PubMed  Google Scholar 

  • Abraham, R.T. 2004. The ATM-related kinase, hSMG-1, bridges genome and RNA surveillance pathways. DNA Repair. 3: 919–925.

    CAS  PubMed  Google Scholar 

  • Ali, A., J. Zhang, S. Bao, L. Liu, D. Otterness, N.M. Dean, R.T. Abraham, and X.F. Wang. 2004. Requirement of protein phosphatase 5 in DNA damage-induced ATM activation. Genes Dev. 18: 249–254.

    Article  CAS  PubMed  Google Scholar 

  • Athma, P., R. Rappaport, and M. Swift. 1996. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast Cancer. Genet Cytogenet. 92: 130–134.

    CAS  Google Scholar 

  • Bache, M., S. Pigorsch, J. Dunst, P. Wurl, A. Meye, F. Bartel, H. Schmidt, F.W. Rath, and H. Taubert. 2001. Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53. Int. J. Cancer. 96: 110–117.

    Article  CAS  PubMed  Google Scholar 

  • Bakkenist, C.J., M.B. Kastan. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421: 499–506.

    Article  CAS  PubMed  Google Scholar 

  • Banin, S., L. Moyal, S. Shieh, Y. Taya, C.W. Anderson, L. Chessa, N.I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 281: 1674–1677.

    Article  CAS  PubMed  Google Scholar 

  • Beamish, H., M.F. Lavin. 1994. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cycle delay. Int J. Radiat Biol. 65: 175–184.

    CAS  PubMed  Google Scholar 

  • Biemond, A. 1957. A Palaeocerebellar atrophy with extra-pyramidal manifestations in association with bronchiectasis and telangiectasis of the conjunctivabulbi as a familial syndrome. In van Bogaert L, Radermacker J, eds. Proc 1st Inter, Congr of Neurological Sciences, Brussels. London. Pergamon Press. 4: 206.

    Google Scholar 

  • Blattner, F.R., G. Plunkett 3rd, C.A. Bloch, N.T. Perna, V. Burland, M. Riley, J. Collado-Vides, J.D. Glasner, C.K. Rode, G.F. Mayhew, J. Gregor, N.W. Davis, H.A. Kirkpatrick, M.A. Goeden, D.J. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli K-12. Science. 277: 1453–1474.

    Article  CAS  PubMed  Google Scholar 

  • Boder, E. 1985. Ataxia-telangiectasia: an overview. In Gatti, R.A., Swift M, eds. Ataxia-Telangiectasia. New York: Alan R Liss, Kroc Foundation Series: 19: 1–63.

    Google Scholar 

  • Boder, E., R.P. Sedgwick. 1957. Ataxia-telangiectasia. A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. A preliminary report on 7 children, an autopsy, and a case history. Univ S Calif Med Bull. 9: 15–28.

    Google Scholar 

  • Boder, E., R.P. Sedgwick. 1963. Ataxia-telangiectasia. A review of 101 cases. In: Walsh G, ed. Little Club Clinics in Developmental Medicine no.8. London: Heinemann Medical Books. 110–118.

    Google Scholar 

  • Bulavin, D.V., Y. Higashimoto, I.J. Popoff, W.A. Gaarde, V. Basrur, O Potapova, E. Appella, and A.J. Fornace Jr. 2001. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature. 411: 102–107.

    Article  CAS  PubMed  Google Scholar 

  • Canman, C.E., A.C. Wolff, C.Y. Chen, A.J. Jr. Fornace, and M.B. Kastan. 1994. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 54: 5054–5058.

    CAS  PubMed  Google Scholar 

  • Canman, C.E., D.S. Lim, K.A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M.B. Kastan, and J.D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281: 1677–1679.

    Article  CAS  PubMed  Google Scholar 

  • Carbonari, M., M. Cherchi, R. Paganelli, G. Giannini, E. Galli, C Gaetan, C. Papetti, and M. Fiorilli. 1990. Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia. N Engl J Med. 322: 73–76.

    Article  CAS  PubMed  Google Scholar 

  • Carney, J.P., R.S. Maser, H. Olivares, E.M. Davis, M. Le Beau, Yates, Jr., 3rd, L. Hays, W.F. Morgan, and J.H. Petrini. 1998. The hMRE11 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell. 93: 477–486.

    Article  CAS  PubMed  Google Scholar 

  • Carson, C.T., R.A. Schwartz, T.H. Stracker, C.E. Lilley, D.V. Lee, and M.D. Weitzman. 2003. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22: 6610–6620.

    Article  CAS  PubMed  Google Scholar 

  • Cedervall, B., P. Kallman, and W.C. Dewey. 1995. Repair of DNA double-strand breaks: errors encountered in the determination of half-life times in pulsed-field gel electrophoresis and neutral filter elution. Radiat Res. 142: 23–28.

    CAS  PubMed  Google Scholar 

  • Cerosaletti, K., P. Concannon. 2004. Independent roles for nibrin and Mre11-Rad50 in the activation and function of Atm.. J. Biol Chem. 279: 38813–38819.

    Article  CAS  PubMed  Google Scholar 

  • Chenevix-Trench, G., A.B. Spurdle, M. Gatei, H. Kelly, A. Marsh, X. Chen, K. Donn, M. Cummings, D. Nyholt, M.A. Jenkins, C. Scott, G.M. Pupo, T. Dork, R. Bendix, J. Kirk, K. Tucker, M.R. McCredie, J.L. Hopper, J. Sambrook., G.J. Mann, and K.K. Khanna. 2002. Dominant negative ATM mutations in breast cancer families. J. Natl. Cancer Inst. 94: 205–215.

    Google Scholar 

  • Cohen, M.M., S.J. Simpson. 1982. The Effect of bleomycin on DNA synthesis in ataxia-telangiectasia lymphoid cells. Environ Mutagen. 4: 27–36.

    CAS  PubMed  Google Scholar 

  • Cornforth, M.W., J.S. Bedford. 1985. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science. 227: 1589–1591.

    CAS  PubMed  Google Scholar 

  • Costanzo, V., K. Robertson, C.Y. Ying, E. Kim, E. Avvedimento, M. Gottesman, D. Grieco, and J. Gautier. 2000. Reconstitution of an ATM-dependent checkpoint that inhibits chromosome DNA replication following DNA damage. Mol Cell. 6: 649–659.

    Article  CAS  PubMed  Google Scholar 

  • Costanzo, V., K. Robertson, and J. Gautier. 2004. Xenopus cell-free extracts to study the DNA damage response. Methods Mol Biol. 280: 213–227.

    CAS  PubMed  Google Scholar 

  • Dalal, S.N., C.M. Schweitzer, J. Gan, and J.A. DeCaprio. 1999. Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol Cell Biol. 19: 4465–4479.

    CAS  PubMed  Google Scholar 

  • De Wit, J., N.G.L. Jaspers, and D. Bootsma. 1981. The rate of DNA synthesis in normal and ataxia-telangiectasia cells after exposure to X-irradiation. Mutat Res. 80: 221–226.

    PubMed  Google Scholar 

  • Dork, T., R. Bendix, M. Bremer, D. Rades, K. Klopper, M. Nicke, B. Skawran, A. Hector, P. Yamini, D. Steinmann, S. Weise, M. Stuhrmann, and J.H. Karstens. 2001. Sprectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res. 61: 7608–7615.

    CAS  PubMed  Google Scholar 

  • Edwards, M.J., A.M.R. Taylor. 1981. Unusual levels of (ADP-ribose) and DNA synthesis in ataxia-telangiectasia cells following γ-ray irradiation. Nature. 287: 745–747.

    Google Scholar 

  • El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumour suppression. Cell. 75: 817–825.

    Article  CAS  PubMed  Google Scholar 

  • Falck, J., N. Mailand, R.G. Syljuasen, J. Bartek, and J. Lukas. 2001. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature. 410: 842–847.

    Article  CAS  PubMed  Google Scholar 

  • Fitzgerald, M.G., J.M. Bean, S.R. Hedge, H. Unsal, D.J. MacDonald, D.P. Harkin, D.M. Finkelstein, K.J. Isselbacher, and D.A. Haber. 1997. Heterozygous ATM mutations do not contribute to early onset breast cancer. Nature. 15: 307–310.

    CAS  Google Scholar 

  • Foray, N., A. Priestly, G. Alsbeith, C. Badie, E.P. Capulas, C.F. Arlett, and E.P. Malaise. 1997. Hypersensitivity of ataxia-telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int J Radiat Biol. 72: 271–283.

    CAS  PubMed  Google Scholar 

  • Goodarzi, A.A., W.D. Block, and S.P. Lees-Miller. 2003. The role of ATM and ATR in DNA damage-induced cell cycle control. Prog Cell Cycle Res. 5: 393–411.

    PubMed  Google Scholar 

  • Goodarzi, A.A., J.C. Jonnalagadda, P. Douglas, D. Young, R. Ye, G.B. Moorhead, S.P. Lees-Miller, and K.K. Khanna. 2004. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J. 23: 4451–4461.

    Article  CAS  PubMed  Google Scholar 

  • Goodarzi, A.A., S.P. Lees-Miller. 2004. Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells. DNA Repair. 3: 753–767.

    Article  CAS  PubMed  Google Scholar 

  • Hamer, G., H.B. Kal, C. H. Westphal, T. Ashley, and D. G. de Rooij. 2004. Ataxia-telangiectasia mutated expression and activation in the Testis. Biology of Reproduction. 70: 1206–1212.

    CAS  PubMed  Google Scholar 

  • Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75: 805–816.

    CAS  PubMed  Google Scholar 

  • Hecht, F., R.D. Koler, D.A. Rigas, G.S. Dahnke, M.P. Case, V. Tisdale, and R.W. Miller. 1966. Leukaemia and lymphocytes in ataxia-telangiectasia. Lancet 2: 1193.

    Google Scholar 

  • Hecht, F., B.K. Hecht. 1990. Cancer in ataxia-telangiectasis patients. Cancer Genet Cytogenet. 46: 9–19.

    CAS  PubMed  Google Scholar 

  • Hecht, F., R.D. Koler, D.A. Rigas, G.S. Dahnke, M.P. Case, V. Tisdale, and R.W. Miller. 1966. Leukaemia and lymphocytes in ataxia-telangiectasis. Lancet. 2: 1193.

    Google Scholar 

  • Hecht, F., B.K. McCaw, and R. Koler. 1973. Ataxia-telangiectasia-clonal growth of translocation lymphocytes. N Engl J Med. 289: 286–291.

    Article  CAS  PubMed  Google Scholar 

  • Higurashi, M., P.E. Conen. 1973. In vitro chromosomal radiosensitivity in ‘chromosomal breakage syndromes’. Cancer. 32: 380–383.

    CAS  PubMed  Google Scholar 

  • Hirao, A., Y.Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S.J. Elledge, and T.W. Mak. 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science. 287: 1824–1827.

    Article  CAS  PubMed  Google Scholar 

  • Houldsworth, J., M.F. Lavin. 1980. Effect of ionizing radiation on DNA synthesis in ataxia-telangiectasia cells. Nucleic Acids Res. 8: 3709–3720.

    CAS  PubMed  Google Scholar 

  • Izatt, L., J. Greenman, S. Hodgson, D. Ellis, S. Watt, G. Scott, C. Jacobs, R. Liebmann, M.J. Zvelebil, C. Mathew, and E. Solomon. 1999. Identification of germline missense mutations and rare allelic variants in ATM gene in early-onset breast cancer. Genes Chromosomes Cancer. 26: 286–294.

    Article  CAS  PubMed  Google Scholar 

  • Janin, N., N. Andrieu., K. Ossian, A. Lauge, M.F. Croquette, C. Griscelli, M. Debre, B. Bressac-de-Paillerets, A. Aurias, and D. Stoppa-Lyonett. 1999. Breast cancer risk in ataxia-telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br. J. Cancer. 80: 1042–1045.

    Article  CAS  PubMed  Google Scholar 

  • Jeggo, P., B. Singleton, H. Beamish, and A. Priestley. 1999. Double strand break rejoining by the Ku-dependent mechanism of non-homologous end-joining. CR ACAD Sci III. 322: 109–112.

    CAS  Google Scholar 

  • Johnson, R.D., M. Jasin. 2000. Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells. EMBO J. 19: 3398–3407.

    Article  CAS  PubMed  Google Scholar 

  • Kastan, M.B., O. Zhan, W.S. EL-Deiry, F Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace, 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 71: 587–597.

    Article  CAS  PubMed  Google Scholar 

  • Khanna, K.K. M.F. Lavin. 1993. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene. 8: 3307–3312.

    CAS  PubMed  Google Scholar 

  • Khanna, K.K., H. Beamish, Y. Yan, K. Hobson, R. Williams, I. Dunn, and M.F. Lavin. 1995. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene 17: 609–618.

    Google Scholar 

  • Khanna, K.K., K.E. Keating, S. Kozlov, S. Scott, M. Gatei, K. Hobson, Y. Taya, B. Gabrielli, D. Chan, S.P. Lees-Miller, and M.F. Lavin. 1998. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet. 20: 398–400.

    Article  CAS  PubMed  Google Scholar 

  • Khosravi, R., R. Maya, T. Gottlieb, M. Oren, Y. Shiloh, and D. Shkedy. 1999. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci USA 96: 14973–14977.

    Article  CAS  PubMed  Google Scholar 

  • Kim, J.S., T.B. Krasieva, V. LaMorte, A.M. Taylor, and K. Yokomori. 2002. Specific recruitment of human cohesin to laser-induced DNA damage. J. Biol. Chem. 277: 45149–45153.

    CAS  PubMed  Google Scholar 

  • Kim, S.T., B. Xu, and M.B. Kastan. 2002. Involvement of the cohesin protein, Smc1, in Atm-dependent independent responses to DNA damage. Genes Dev. 16: 560–570.

    Article  CAS  PubMed  Google Scholar 

  • Kozlov, S., N. Gueven, K. Keating, J. Ramsay, and M.F. Lavin. 2003. ATP activates ataxia-telangiectasia mutated (ATM) in vitro. Importance of autophosphorylation. J. Biol Chem. 278: 9309–9317.

    CAS  PubMed  Google Scholar 

  • Larson, G. 1998. An allelic variant at the ATM locus is implicated in breast cancer susceptibility. Genetic Testing. 1: 165–170.

    CAS  Google Scholar 

  • Lavin, M.F., S. Scott, P. Chen, S. Kozlov, N. Gueven, and G. Birrell. 2003. In Handbook of Cell Signaling vol 3. (Eds. R.A. Bradshaw and E.A. Dennis) Elsevier Science, pp 225–236.

    Google Scholar 

  • Lavin, M.F. 2004. The Mre11 complex and ATM: a two-way functional interaction in recognising and signalling DNA double strand breaks. DNA Repair. 3: 1515–1520.

    CAS  PubMed  Google Scholar 

  • Lavin, M.F., H. Lederman. 2004. Chromosomal Breakage Syndromes associated with immunodeficiency. In: Stiehm E.R. ed. Immunologic Disorders in Infants & Children. 580–605.

    Google Scholar 

  • Lavin, M.F., Y. Shiloh. 1997. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol. 15: 177–202.

    Article  CAS  PubMed  Google Scholar 

  • Lee, J.H. T.T. Paull. 2004. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science. 304: 93–96.

    CAS  PubMed  Google Scholar 

  • Lehmann, A.R., M.R. James, and S. Stevens. 1982. Miscellaneous observations on DNA repair in ataxia-telangiectasia. In Bridges B A, Harnden D G, eds. A Cellular and Molecular Link with Cancer. New York: John Wiley and Sons. 347–353.

    Google Scholar 

  • Lim, D.S., S.T. Kim, B. Xu, R.S. Maser, J. Lin, J.H. Petrini, and M.B. Kastan. 2000. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature. 404: 613–617.

    CAS  PubMed  Google Scholar 

  • Maya, R., M. Balass, S.T. Kim, D. Shkedy, J.F. Leal, O. Shifman, M. Moas, T. Buschmann, Z. Ronai, Y. Shiloh, M.B. Kastan, E. Katzir, and M. Oren. 2001. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15: 1067–1077.

    Article  CAS  PubMed  Google Scholar 

  • McFarlin, D.E., W. Strober, and T.A. Waldmann. 1972. Ataxia-telangiectasia. Medicine. 51: 281–314.

    CAS  PubMed  Google Scholar 

  • Meek, K., S. Gupta, D.A. Ramsden, and S.P. Lees-Miller. 2004. The DNA-dependant protein kinase: the director at the end. Immunol Rev. 200: 132–141.

    Article  CAS  PubMed  Google Scholar 

  • Miller, R.W. 1967. Persons with exceptionally high risk of leukaemia. Cancer Res. 27: 2420–2423.

    CAS  PubMed  Google Scholar 

  • Mirzoeva, O.K. J.H. Petrini. 2001. DNA damage-dependent nuclear dynamics of the Mre11 complex. Mol Cell Biol. 21: 281–288.

    Article  CAS  PubMed  Google Scholar 

  • Moore, J.K. J.E. Haber. 1996. Cell cycle and genetic requirements of two pathways of nonhomologous joining repair of double-strand breaks in Saccharomyces cerevisiae. Mol Cell Biol. 16: 2164–2173.

    CAS  PubMed  Google Scholar 

  • Morrell, D., C.L. Chase, L.L. Kupper, and M. Swift. 1986. Diabetes mellitus in ataxiatelangiectasia, Fanconis anemia, xeroderma pigmentosum, common variable immune deficiency, and severe combined immune deficiency families. Diabetes. 35: 143–147.

    CAS  PubMed  Google Scholar 

  • Morrell, D., C.L. Chase, and M. Swift. 1990. Cancers in 44 families with ataxia-telangiectasia. Cancer Genet Cytogenet. 50: 119–123.

    Article  CAS  PubMed  Google Scholar 

  • Morris, C., R. Mohamed, and M.F. Lavin. 1983. DNA replication and repair in atxia-telangiectasia cells exposed to bleomycin. Mutat Res. 112: 67–74.

    CAS  PubMed  Google Scholar 

  • Nagasawa, H., J.B. Little. 1983. Comparison of kinetics of X-ray-induced cell killing in normal, ataxia-telangiectasia and hereditary retinoblastoma fibroblasts. Mutat Res. 109: 297–308.

    CAS  PubMed  Google Scholar 

  • Nakanishi, K., T. Taniguchi, V. Ranganathan, H.V New, L.A. Moreau, M. Stotsky, C.G. Mathew, M.B. Kastan, D.T. Waever, and A.D. D’Andrea. 2002. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat, Cell Biol. 4: 913–920.

    Article  CAS  Google Scholar 

  • Olsen, J.H., J.M. Hahnemann, A.L. Borresen-Dale, K. Brondum-Nielsen, L. Hammarstrom, R. Kleinerman, H. Kaariainen, T. Lonnqvist, R. Sankila, N. Seersholm, S. Tretli, J. Yuen, J.D. Boice Jr, and M. Tucker. 2001. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J. Natl. cancer Inst. 93: 121–127.

    Article  CAS  PubMed  Google Scholar 

  • Pandita, T.K., W.N. Hittleman. 1992. Initial chromosome damage but not DNA damage is greater in ataxia-telangiectasia cells. Radiat Res. 130: 94–103.

    CAS  PubMed  Google Scholar 

  • Paterson, M.C., P.J. Smith. 1979. Ataxia-telangiectasia, an inherited human disorder involving hypersensitivity to ionizing radiation and related DNA-damaging chemicals. Annu Rev Genet. 13: 291–318.

    Article  CAS  PubMed  Google Scholar 

  • Paull, T.T., M. Gellert. 1998. The 3′ to 5′ exonuclease activity of Mre11 facilitates repair of DNA double strand breaks. Mol Cell. 1: 969–979.

    Article  CAS  PubMed  Google Scholar 

  • Peng, C.Y., P.R. Graves, R.S. Thoma, Z. Wu, A.S. Shaw, and H. Piwnica-Worms. 1997. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on Ser-216. Science. 277: 1501–1505.

    Article  CAS  PubMed  Google Scholar 

  • Peterson, R.D., W.D. Kelly, and R.A. Good. 1964. Ataxia-telangiectasia: its association with a defective thymus, immunological-defective thymus, immunological-deficiency disease, and malignancy. Lancet. 1: 1189–1193.

    CAS  PubMed  Google Scholar 

  • Pfeiffer, P., W. Goedecke, S. Kuhfittig-Kulle, and G. Obe. 2004. Pathways of DNA double-strand break repair and their impact on the prevention and formation of chromosomal aberrations. Cytogenet Genome Res. 104: 7–13.

    Article  CAS  PubMed  Google Scholar 

  • Powers, J.T., S. Hong, C.N. Mayhew, P.M. Rogers, E.S. Knudsen, and D.G. Johnson. 2004. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol Cancer Res. 2: 203–214.

    CAS  PubMed  Google Scholar 

  • Rary, J.M., M.A. Bender, and T.E. Kelly. 1975. A 14/14 marker chromosome lymphocyte clone in ataxia-telangiectasia. J Hered. 66: 33–35.

    CAS  PubMed  Google Scholar 

  • Saito, H., Y. Minamiya, S. Saito, and J. Ogawa. 2002. Endothelial Rho and Rho kinase regulate neutrophil migration via endothelial myosin light chain phosphorylation. J. Leuko Biol. 72: 829–836.

    CAS  PubMed  Google Scholar 

  • Savitsky, K., A. Bar-Shira, G. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A Tagle, S. Smith, T. Uziel, S. Sfez, M. Ashkenazi, I. Pecker, M. Fryman, R. Harnik, S.R. Patanjali, A. Simmons, G.A. Clines, A. Sartiel, R.A. Gatti, L. Chessa, O. Sanal, M.F. Lavin, N.G.J. Jaspers, A.M.R. Taylor, C.F. Arlett, T. Miki, S.M. Weissman, M. Lovett, F.S. Collins, and Y. Shiloh (1995) A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science. 268: 1749–1753.

    CAS  PubMed  Google Scholar 

  • Scott, S.P., R. Bendix, P. Chen, R. Clark, T. Dork, and M.F. Lavin. 2002. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proc Natl Acad Sci USA. 99: 925–930.

    CAS  PubMed  Google Scholar 

  • Scott, D. and F. Zampetti-Bosseler. 1982. Cell cycle dependence of mitotic delay in X-irradiated normal and ataxia-telangiectasia fibroblasts. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 42: 679–683.

    CAS  PubMed  Google Scholar 

  • Sedgwick, R.P. and E. Boder (1991) Ataxia-telangiectasia. In Vianney De Jong J.M.B., ed. Hereditary Neuropathies and Spinocerebellar Atrophies. Amsterdam: Elsevier Science, pp 347–423. 1991.

    Google Scholar 

  • Shiloh, Y., E. Tabor, and Y. Becker. 1983. Abnormal response of ataxia-telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanism. Carcinogenesis. 4: 1317–1322.

    CAS  PubMed  Google Scholar 

  • Shiloh, Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nature Rev Cancer. 3: 155–168.

    Article  CAS  Google Scholar 

  • Spector, B.D., A.H. Filipovich, G.S.III. Perry, and J.H. Kersey. 1982. Epidemiology of cancer in ataxia-telangiectasia. In Bridges B A, Harnden D G, eds. Ataxia-Telangiectasia. Chichester: Wiley. 103–138.

    Google Scholar 

  • Stewart, G.S., R.S. Maser, T. Stankovic, D.A. Bressan, M.I. Kaplan, N.G. Jaspers, A. Raams, P.J. Byrd, J.H. Petrini, and A.M. Taylor. 1999. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99: 577–587.

    Article  CAS  PubMed  Google Scholar 

  • Stewart, G.S., J.I. Last, T. Stankovic, N. Haites, A.M. Kidd, P.J. Bryd, and A.M. Taylor. 2001. Residual ataxia-telangiectasia mutated protein function in cells from ataxia-telangiectasia patients, with 5762ins 137 and 7271T >G mutations showing a less severe phenotype. J. Biol Chem. 276: 30133–30141.

    CAS  PubMed  Google Scholar 

  • Stracker, T.H., J.W. Theunissen, M. Morales, and J.H. Petrini. 2004. The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together. DNA Repair (Amst). 3: 845–854.

    CAS  Google Scholar 

  • Swift, M., D. Morrell, R.B. Massey, and C.L. Chase. 1991. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Eng J Med. 325: 1831–1836.

    Article  CAS  Google Scholar 

  • Taylor, A.M.R. 1982. Cytogenetics of ataxia-telangiectasia. In bridges B A, Harnden D G, eds. Ataxia-Telangiectasia-A Cellular and Molecular Link Between Cancer, Neuropathology and Immune Deficiency. New York: Wiley. 53–83.

    Google Scholar 

  • Taylor, A.M., D.G. Harnden, C.F. Arlett, S.A. Harcourt, A.R. Lehmann, S. Stevens, and B.A. Bridges. 1975. Ataxia-Telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 4: 427–429.

    Google Scholar 

  • Taylor A.M., J.R. Matcalfe, J.M. Oxford, and D.G. Harnden. 1976. Is chromatid-type damage in ataxia-telangiectasia after irradiation at G0 a consequence of defective repair? Nature. 260: 441–443.

    CAS  PubMed  Google Scholar 

  • Teraoka, S.N., K.E. Malone, D.R. Doody, N.M. Suter, E.A. Ostrander, J.R. Daling, and P. Concannon 2001. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer. 92: 479–487.

    Article  CAS  PubMed  Google Scholar 

  • Thompson, T., C. Tovar, H. Yang, D. Carvajal, B.T. Vu, Q. Xu, G.M. Wahl, D.C. Heimbrook, and L.T. Vassilev. 2004. Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J. Biol Chem. (October 6, published ahead of print).

    Google Scholar 

  • Trujillo, K.M., S.S. Yuan, E.Y. Lee, and P. Sung. 1998. Nuclease activities in a complex of human recombination and DNA repair factors Rad50, Mre11 and p95. J. Biol Chem. 273: 21447–21450.

    CAS  PubMed  Google Scholar 

  • Uziel, T., Y. Lerenthal, L. Moyal, Y. Andegeko, L. Mittelman, and L. Shiloh. 2003. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22: 5612–5621.

    Article  CAS  PubMed  Google Scholar 

  • Waldmann T.A. Immunological abnormalities in ataxia-telangiectasia. 1982. In Bridges B A, Harden D G, eds. Ataxia-Telaniectasia: A Cellular and Molecular Link Between Cancer Neuropathology and Immune Deficiency. New York: Wiley. 37–51.

    Google Scholar 

  • Wang, Y., D. Cortez, P. Yazdi, N. Neff, S.J. Elledge, and J. Qin. 2000. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14: 927–939.

    CAS  PubMed  Google Scholar 

  • Wang, B., S. Matsuoka, P.B. Carpenter, and S.J. Elledge. 2002. 53BP1, a mediator of the DNA damage checkpoint. Science. 298: 1435–1438.

    CAS  PubMed  Google Scholar 

  • Xu, B., S.T. Kim, and M.B. Kastan. 2001. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol. 21: 3445–3450.

    CAS  PubMed  Google Scholar 

  • Xu, B. S.T. Kim, D.S. Lim, and M.B. Kastan. 2002. Two molecularly distinct g(2)/m checkpoints are induced by ionizing irradiation. Mol. Cell Biol. 22: 1049–1059.

    CAS  PubMed  Google Scholar 

  • Zacchi, P., M. Gostissa, T. Uchida, C. Salvagno, F. Avolio, S. Volinia, Z. Ronai, G. Blandino, C. Schneider, and G. Del Sal. 2002. The prolyl isomerase Pin1 reveals a mechanism to control p5 functions after genotoxic insults. Nature. 419: 853–857.

    Article  CAS  PubMed  Google Scholar 

  • Yazdi, P.T., Y. Wang, S. Zhao, N. Patel, E.Y. Lee, and J. Qin. 2002. SMC1 is a downstream effector in the ATM/NBS1 branch of the human phase checkpoint. Genes Dev. 16: 571–582.

    Article  CAS  PubMed  Google Scholar 

  • Zampetti-Besseler, F. and D. Scott. 1981. Cell death, chromosome damage and mitotic delay in normal human, ataxia-telangiectasia and retinoblastoma fibroblasts after x-irradiation. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 39: 547–558.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer

About this chapter

Cite this chapter

Lavin, M.F. et al. (2005). ATM and Cellular Response to DNA Damage. In: Back, N., Cohen, I.R., Kritchevsky, D., Lajtha, A., Paoletti, R., Nigg, E.A. (eds) Genome Instability in Cancer Development. Advances in Experimental Medicine and Biology, vol 570. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3764-3_16

Download citation

Publish with us

Policies and ethics